SCHEMBL1126548

SCHEMBL1126548

COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3nccn3CN(C)C)c3ncccc23)c1F

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127000 0.94 FGFR3 (0.64) FGFR3
SCHEMBL1126456 0.90 FGFR3 (0.65) FGFR3
SCHEMBL1126311 0.85 FGFR3 (0.64) FGFR3
SCHEMBL1126769 0.83 FGFR3 (0.61) FGFR3
SCHEMBL1126549 0.79 FGFR3 (0.75) FGFR3
SCHEMBL1126014 0.78 FGFR3 (0.61) FGFR3
SCHEMBL1126540 0.77 FGFR3 (0.58) FGFR3
SCHEMBL1126407 0.76 FGFR3 (0.59) FGFR3
SCHEMBL1126297 0.76 FGFR3 (0.57) FGFR3
SCHEMBL12678209 0.74 FGFR3 (1.00) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS Novartis AG (CH) 2011-02-16 EP disclosed